{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:01:15Z","timestamp":1793041275133,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>The spine represents the site which is most frequently affected by bone metastases in patients with systemic cancer. Of all local treatment options, combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) provides both, instantaneous stabilization and immediate pain relief. We here report on the long-term outcomes of the largest cohort treated with Kypho-IORT to date.\n<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Between 2009 and 2019 a total of 104 patients underwent Kypho-IORT to vertebral tumors in the thoracic, lumbar, or sacral spine with transpedicular kyphoplasty and intraoperative irradiation with a needle-shaped electronic brachytherapy source at our center. Patients were treated either <jats:italic>on trial<\/jats:italic>, within the prospective Kypho-IORT studies (NCT01280032 and NCT02773966), or, after completion of the study, <jats:italic>off trial<\/jats:italic> but compliant with the study protocol. Follow-up and imaging with computed tomography (CT) or magnetic resonance imaging was scheduled after 3 and 6\u00a0months and then bi-annually.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 143 vertebrae (89 thoracic spine, 53 lumbar spine, and 1 sacral spine) were treated in 104 patients. The median follow-up was 14.5\u00a0months (range 0.4\u2013109). Local progression occurred in 10 patients (10 vertebrae) after a median time of 22.3\u00a0months (range 1.5\u201373) resulting in local control rates of 97.1, 95.9, and 94.2% at 6, 12, and 24\u00a0months, respectively. Overall survival was 74.6, 61.7, and 50.3% at 6, 12, and 24\u00a0months, respectively. A single serious adverse event was reported.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In addition to immediate pain reduction and stabilization, Kypho-IORT shows excellent long-term local control with minimal side effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13014-020-01715-z","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T14:03:10Z","timestamp":1605189790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-term outcome after combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) for vertebral tumors"],"prefix":"10.1186","volume":"15","author":[{"given":"Frederic","family":"Bludau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Obertacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne Mathias","family":"Ruder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"issue":"4","key":"1715_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.nec.2004.04.018","volume":"15","author":"RG Perrin","year":"2004","unstructured":"Perrin RG, Laxton AW. Metastatic spine disease: epidemiology, pathophysiology, and evaluation of patients. Neurosurg Clin N Am. 2004;15(4):365\u201373.","journal-title":"Neurosurg Clin N Am"},{"key":"1715_CR2","volume-title":"Bone tumors: diagnosis, treatment and prognosis","author":"AG Huvos","year":"1987","unstructured":"Huvos AG. Bone tumors: diagnosis, treatment and prognosis. 2nd ed. New York: W.B. Saunders Company and Cbs Educational and Professional Publishing; 1987.","edition":"2"},{"issue":"1","key":"1715_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","volume":"7","author":"S Lutz","year":"2017","unstructured":"Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4\u201312.","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"1715_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1470-2045(11)70008-0","volume":"12","author":"J Berenson","year":"2011","unstructured":"Berenson J, Pflugmacher R, Jarzem P, Zonder J, Schechtman K, Tillman JB, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011;12(3):225\u201335.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1715_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/1049909118819460","volume":"36","author":"KM Prezzano","year":"2019","unstructured":"Prezzano KM, Prasad D, Hermann GM, Belal AN, Alberico RA. Radiofrequency ablation and radiation therapy improve local control in spinal metastases compared to radiofrequency ablation alone. Am J Hosp Palliat Care. 2019;36(5):417\u201322.","journal-title":"Am J Hosp Palliat Care"},{"issue":"5","key":"1715_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","volume":"13","author":"DN Khalil","year":"2016","unstructured":"Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat Rev Clin Oncol. 2016;13(5):273\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"1715_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jare.2019.07.002","volume":"20","author":"L Botta","year":"2019","unstructured":"Botta L, Dal Maso L, Guzzinati S, Panato C, Gatta G, Trama A, et al. Changes in life expectancy for cancer patients over time since diagnosis. J Adv Res. 2019;20:153\u20139.","journal-title":"J Adv Res"},{"issue":"1","key":"1715_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.21873\/anticanres.13107","volume":"39","author":"K Kokkonen","year":"2019","unstructured":"Kokkonen K, Tasmuth T, Lehto JT, Kautiainen H, Elme A, J\u00e4\u00e4skel\u00e4inen A-S, et al. Cancer patients\u2019 symptom burden and health-related quality of life (HRQoL) at tertiary cancer center from 2006 to 2013: a cross-sectional study. Anticancer Res. 2019;39(1):271\u20137.","journal-title":"Anticancer Res"},{"issue":"5","key":"1715_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.spinee.2017.09.011","volume":"18","author":"F Bludau","year":"2018","unstructured":"Bludau F, Welzel G, Reis T, Schneider F, Sperk E, Neumaier C, et al. Phase I\/II trial of combined kyphoplasty and intraoperative radiotherapy in spinal metastases. Spine J. 2018;18(5):776\u201381.","journal-title":"Spine J"},{"issue":"1","key":"1715_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12885-019-5666-5","volume":"19","author":"F Bludau","year":"2019","unstructured":"Bludau F, Welzel G, Reis T, Abo-Madyan Y, Sperk E, Schneider F, et al. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases\u2014a randomized phase III study. BMC Cancer. 2019;19(1):430.","journal-title":"BMC Cancer"},{"issue":"10","key":"1715_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s000660050061","volume":"175","author":"S Koswig","year":"1999","unstructured":"Koswig S, Budach V. Remineralisation und Schmerzlinderung von Knochenmetastasen nach unterschiedlich fraktionierter Strahlentherapie (10mal 3 Gy vs. 1mal 8 Gy)Eine prospektive Studie. Strahlenther Onkol. 1999;175(10):500\u20138.","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"1715_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","volume":"27","author":"ZA Husain","year":"2017","unstructured":"Husain ZA, Sahgal A, De Salles A, Funaro M, Glover J, Hayashi M, et al. Stereotactic body radiotherapy for de novo spinal metastases: systematic review. J Neurosurg Spine. 2017;27(3):295\u2013302.","journal-title":"J Neurosurg Spine"},{"issue":"10185","key":"1715_CR13","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051\u20138.","journal-title":"Lancet"},{"issue":"5","key":"1715_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/0284186X.2012.666637","volume":"51","author":"U-K Chang","year":"2012","unstructured":"Chang U-K, Cho W-I, Kim M-S, Cho CK, Lee DH, Rhee CH. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol. 2012;51(5):589\u201395.","journal-title":"Acta Oncol"},{"issue":"2","key":"1715_CR15","first-page":"99","volume":"5","author":"EH Balagamwala","year":"2018","unstructured":"Balagamwala EH, Naik M, Reddy CA, Angelov L, Suh JH, Djemil T, et al. Pain flare after stereotactic radiosurgery for spine metastases. J Radiosurg SBRT. 2018;5(2):99\u2013105.","journal-title":"J Radiosurg SBRT"},{"issue":"4","key":"1715_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.03.022","volume":"86","author":"A Chiang","year":"2013","unstructured":"Chiang A, Zeng L, Zhang L, Lochray F, Korol R, Loblaw A, et al. Pain flare is a common adverse event in steroid-na\u00efve patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(4):638\u201342.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1715_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.radonc.2019.08.026","volume":"141","author":"F Mantel","year":"2019","unstructured":"Mantel F, Sweeney RA, Klement RJ, Hawkins MA, Belderbos J, Ahmed M, et al. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: long-term results of a prospective phase 2 study. Radiother Oncol. 2019;141:62\u20136.","journal-title":"Radiother Oncol"},{"issue":"30","key":"1715_CR18","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","volume":"27","author":"PS Rose","year":"2009","unstructured":"Rose PS, Laufer I, Boland PJ, Hanover A, Bilsky MH, Yamada J, et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol. 2009;27(30):5075\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1715_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ijrobp.2015.05.035","volume":"93","author":"N Moussazadeh","year":"2015","unstructured":"Moussazadeh N, Lis E, Katsoulakis E, Kahn S, Svoboda M, DiStefano NM, et al. Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2015;93(2):361\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"1715_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/atm.2019.04.68","volume":"7","author":"DT Lockney","year":"2019","unstructured":"Lockney DT, Hopkins B, Lockney NA, Coleman CZ, Rubin E, Lis E, et al. Adjacent level fracture incidence in single fraction high dose spinal radiosurgery. Ann Transl Med. 2019;7(10):211.","journal-title":"Ann Transl Med"},{"issue":"8","key":"1715_CR21","first-page":"830","volume":"47","author":"R Pflugmacher","year":"2006","unstructured":"Pflugmacher R, Schroeder RJ, Klostermann CK. Incidence of adjacent vertebral fractures in patients treated with balloon kyphoplasty: two years\u2019 prospective follow-up. Acta Radiol (Stockholm, Sweden: 1987). 2006;47(8):830\u201340.","journal-title":"Acta Radiol (Stockholm, Sweden: 1987)"},{"issue":"3","key":"1715_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.zemedi.2013.10.006","volume":"24","author":"F Schneider","year":"2014","unstructured":"Schneider F, Clausen S, Jahnke A, Steil V, Bludau F, Sutterlin M, et al. Radiation protection for an intraoperative X-ray source compared to C-arm fluoroscopy. Z Med Phys. 2014;24(3):243\u201351.","journal-title":"Z Med Phys"},{"key":"1715_CR23","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1016\/j.wneu.2018.08.182","volume":"120","author":"O Barzilai","year":"2018","unstructured":"Barzilai O, McLaughlin L, Amato M-K, Reiner AS, Ogilvie SQ, Lis E, et al. Minimal access surgery for spinal metastases: prospective evaluation of a treatment algorithm using patient-reported outcomes. World Neurosurg. 2018;120:e889\u2013901.","journal-title":"World Neurosurg"},{"issue":"5","key":"1715_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/cncr.31870","volume":"125","author":"O Barzilai","year":"2019","unstructured":"Barzilai O, Versteeg AL, Sahgal A, Rhines LD, Bilsky MH, Sciubba DM, et al. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: a multicenter, international study. Cancer. 2019;125(5):770\u20138.","journal-title":"Cancer"},{"issue":"19","key":"1715_CR25","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","volume":"94","author":"F Saad","year":"2002","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;94(19):1458\u201368.","journal-title":"J Natl Cancer Inst"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-020-01715-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T14:09:16Z","timestamp":1605190156000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01715-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01715-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The underlying trials (NCT01280032 and NCT02773966) were approved by the institutional review board, Ethikkommission II, Mannheim Medical Faculty, Heidelberg University. All patients gave their written consent before participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LW, GW, UO, FW and AMR have no competing interests to disclose. FB and FS report grants and personal fees from Carl Zeiss Meditec AG, during the conduct of the study; FG reports grants, personal fees, and patents from or related to Carl Zeiss Meditec AG, grants from Elekta AB; grants and personal fees from NOXXON Pharma AG, personal fees from Bristol-Myers Squibb, personal fees from Roche Pharma AG, personal fees from MSD Sharp and Dohme GmbH, personal fees from AstraZeneca GmbH, non-financial support from Oncare GmbH, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}